Taleigh Corporation, et al.; Proposed Consent Agreement With Analysis to Aid Public Comment

Riepilogo

In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would prohibit, among other things, two marketing corporations and the owner from misrepresenting that any product is new or unique, the existence or conclusions of any test or study, or that an endorsement for any product represents the typical experience of people who use it. The consent agreement would require the respondents to possess scientific evidence to substantiate any representation regarding the performance, benefits, efficacy or safety of any weight-loss or stop-smoking product, or of any food, dietary supplement, drug, or device. In addition, the consent agreement would require the owner to post a $300,000 performance bond, or to establish an escrow account in the amount of $300,000, as a condition of advertising, promoting, selling or distributing any weight-loss or smoking deterrent or cessation product.